3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Gastrointestinal Stromal Tumors
2
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Advanced or Metastatic Solid Tumors
2
Thymoma
1
Solid Tumor
1
Sarcoma
1
Piebaldism
1
Osteosarcoma
1
Nasopharyngeal Carcinoma
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Advanced Solid Tumor
1
Advanced Renal Cell Carcinoma (aRCC)
1
Advanced Refractory Solid Tumors
1
Interventions
Carboplatin
47
Etoposide
46
durvalumab
28
atezolizumab
28
Cisplatin
21
Topotecan
19
pembrolizumab
15
PM 01183
15
Nivolumab
12
Specimen Handling
11
anlotinib
9
Radiotherapy
9
Paclitaxel
9
Drug Therapy
9
Temozolomide
8
Magnetic Resonance Spectroscopy
8
AMG 757
8
Radiosurgery
7
Platinum
7
Irinotecan
7
toripalimab
6
olaparib
6
Biopsy
6
Ipilimumab
5
Injections
5
Docetaxel
5
Bevacizumab
5
trilaciclib
4
tremelimumab
4
tislelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
envafolimab
×
1 year
×
Clear all
No trials found.